Study number 8529-369
Dates
Feb 02 2025-Mar 03 2025
Location
Daytona Beach, Florida
Age
18-60
Gender
Male or Female
Compensation
$5,032
Group
3b1 OR 3b2
The investigational drug in this research study is being developed for the treatment of a type of peripheral nerve disease called Chronic Inflammatory Demyelinating Polyneuropathy, a disorder that involves progressive weakness and reduced senses in the arms and legs.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Men and Women, Age 18-60
- Body Mass Index between 18-32
- Study involves 6 total overnights at our clinic, 4 follow-up visits, and 4 phone calls
- Compensation up to $5,032 may be provided for time and participation
- Refer a friend to receive $750 per qualified referral
Call now to schedule your screening appointment.
Group 3b1:
Check-in: Feb 2
Check-out: Feb 7
Phone Call: Feb 8 & 9
Check-in: Feb 10
Check-out: Feb 11
Phone Call: Feb 12 & 14
Follow up visits: Feb 13, 17, 24, Mar 3
OR
Group 3b2:
Check-in: Feb 16
Check-out: Feb 21
Phone Call: Feb 22 & 23
Check-in: Feb 24
Check-out: Feb 25
Phone Call: Feb 26 & 28
Follow up visits: Feb 27, Mar 3, 10, 17
Compensation Schedule:
Day 9: $3,000
Day 15: $790
Day 29: $1,242